Astex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study28 August 2013/in 2013, NewsAstex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study. https://astx.com/wp-content/uploads/2019/11/logo_white.png 0 0 webadmin https://astx.com/wp-content/uploads/2019/11/logo_white.png webadmin2013-08-28 14:22:372016-11-24 12:47:49Astex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study
